University of Szeged

Futó vizsgálatok

• Még nem toboroz

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· 3. fázis· Eli Lilly and Company· Forrás

• Még nem toboroz

  A study to compare heart failure medicines in one combined pill with usual care.

  2026-526510-90-00· 3. fázis· Institut De Recherches Internationales Servier IRIS· Forrás

• Még nem toboroz

  AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

  NCT07931573· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study

  2026-526648-11-00· 2/3. fázis· Shenzhen Oculgen Biomedical Technology Co. Ltd.· Forrás

• Toboroz

  Lactic Acid Bacteria in Functional Diarrheal Disorders

  NCT07916688· Szeged University· Forrás

• Toboroz

  Phase 1b/2 Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIde)

  2025-523010-89-00· 1/2. fázis· 35Pharma Inc.· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).

  2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes

  NCT07843485· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

  NCT07843498· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease

  NCT07843472· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis

  2026-525673-39-00· 2. fázis· Apollo Therapeutics Limited· Forrás

• Toboroz

  A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  NCT07705555· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Phase 2 Randomized, Double-blind, Placebo-controlled Study of Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma

  2025-524793-42-00· 2. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  NCT07481981· 3. fázis· Insmed Incorporated· Forrás

• Toboroz

  A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.

  2025-522076-85-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  NCT07662109· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  NCT07662213· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  2025-524894-17-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  NCT07668388· 2. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  NCT07599813· 2. fázis· Apollo Therapeutics Ltd· Forrás

• Toboroz

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776· 3. fázis· Amgen· Forrás

• Toboroz

  BIO|STREAM.CSP Study

  NCT07393009· Biotronik SE & Co. KG· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  NCT07564414· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  2025-523938-10-00· 3. fázis· Eyepoint Inc.· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Toboroz

  Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema

  2025-522231-34-00· 3. fázis· Alvotech Swiss AG· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

  NCT07424144· 3. fázis· Sanofi· Forrás

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Toboroz

  Hungarian National Systemic Amyloidosis Registry

  NCT07689331· Semmelweis University· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  Efficacy and safety of a combined therapy in the symptomatic treatment of diabetic sensorimotor polyneuropathy - a prospective, randomized, controlled, parallel group, double-blind, double-dummy 3-arm trial (ARIEL)

  2025-521985-82-00· 2. fázis· Woerwag Pharma GmbH & Co. KG· Forrás

• Toboroz

  Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  NCT07404865· 3. fázis· Vor Biopharma· Forrás

• Toboroz

  A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.

  2025-523826-41-00· 1. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.

  2025-522553-19-00· 2/3. fázis· Kardigan Inc.· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  NCT07190300· 1/2. fázis· Novartis Pharmaceuticals· Forrás

Showing 50 of 188.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Elhízás7 toboroz
• 2-es típusú cukorbetegség6 toboroz
• Atópiás dermatitisz (ekcéma)6 toboroz
• Crohn-betegség6 toboroz
• Szívelégtelenség6 toboroz
• Időskori makuladegeneráció5 toboroz
• Magas vérnyomás5 toboroz
• Gyermekkori daganatok4 toboroz
• Diabéteszes retinopátia3 toboroz
• Krónikus limfoid leukémia (CLL)3 toboroz
• Krónikus vesebetegség3 toboroz
• Pikkelysömör3 toboroz
• Pitvarfibrilláció3 toboroz
• Pulmonális artériás hipertónia3 toboroz
• Sjögren-szindróma3 toboroz
• Stroke (szélütés)3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Colitis ulcerosa2 toboroz
• Dermatomyositis and polymyositis (myositis)2 toboroz
• Dilated cardiomyopathy2 toboroz
• Graves' disease2 toboroz
• Hidradenitis suppurativa2 toboroz
• Mielóma multiplex2 toboroz
• Prosztatarák2 toboroz
• Tüdőrák2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Amiloidózis1 toboroz
• Antiphospholipid syndrome1 toboroz
• Aortic stenosis1 toboroz
• Arthritis psoriatica1 toboroz
• Asztma1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Depresszió1 toboroz
• Diabetic neuropathy1 toboroz
• Follikuláris limfóma1 toboroz
• Glioblasztóma1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hodgkin-limfóma1 toboroz
• Hólyagrák1 toboroz
• Huntington-kór1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Irritable bowel syndrome1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Lupus (SLE)1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Myasthenia gravis1 toboroz
• Neuroendokrin daganatok1 toboroz
• Petefészekrák1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Rheumatoid arthritis1 toboroz
• Szarkóma1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vastagbélrák1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Lezárult

  A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis

  NCT07222189· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  NCT07415954· 2. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07533175· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  NCT07284901· 3. fázis· Kailera· Forrás

• Fut, nem toboroz

  Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

  NCT07311850· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  NCT07284875· 3. fázis· Kailera· Forrás

• Toboroz

  A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

  2024-520201-39-00· 2. fázis· Odyssey Therapeutics Inc.· Forrás

• Még nem toboroz

  Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

  NCT07118449· 2. fázis· XyloCor Therapeutics, Inc.· Forrás

• Lezárult

  Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria.

  2024-518786-10-01· 2. fázis· Evommune Inc.· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.

  NCT06637631· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Lezárult

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

  NCT06534411· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  CHRONDI

  2024-513595-17-00· 2. fázis· Orion Corporation· Forrás

• Fut, nem toboroz

  Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

  NCT06321601· 3. fázis· Amgen· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis

  NCT06624228· 3. fázis· UCB Biopharma SRL· Forrás

• Lezárult

  Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

  NCT06579105· 2. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

  NCT06525220· 3. fázis· Genmab· Forrás

• Lezárult

  A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission.

  NCT06176560· 3. fázis· Faes Farma S.A.· Forrás

• Lezárult

  A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

  NCT06333860· 4. fázis· AbbVie· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

  NCT06238817· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with moderate to severe endometriosis-related pain

  2022-501310-57-00· 2. fázis· Organon LLC· Forrás

• Lezárult

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

  NCT06066528· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

  NCT06034743· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy

  2022-502316-36-00· 4. fázis· Myokardia Inc.· Forrás

• Lezárult

  A study in people with moderately to severely active ulcerative colitis to see how well an investigational treatment called PB016 works and how safe it is compared to a licensed treatment called Entyvio®.

  2022-502778-18-00· 3. fázis· Polpharma Biologics S.A.· Forrás

• Lezárult

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· 3. fázis· Takeda· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

  NCT05923099· 2. fázis· LEO Pharma· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

  NCT05952869· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

  NCT05980949· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Toboroz

  An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

  NCT05907057· 3. fázis· Servier Affaires Médicales· Forrás

• Lezárult

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod in Pediatric Participants with Moderately to Severely Active Crohn's Disease with an Inadequate Response to Conventional Therapy

  2023-508777-91-00· 2/3. fázis· Celgene International II S.a.r.l.· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

  NCT05767034· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

  2024-517612-29-00· 4. fázis· The Brigham And Women’s Hospital Inc.· Forrás

• Leállították

  A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT05592275· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

  NCT05615220· 3. fázis· Emalex Biosciences Inc.· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

Showing 50 of 102.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hipertrófiás kardiomiopátia15 munka · 5 vizsgálat
• Hidradenitis suppurativa7 munka · 5 vizsgálat
• Dystonia7 munka · 0 vizsgálat